ATYR vs CVX · rev $190.0K vs P/E 17, rev $118.66B
aTyr Pharma, Inc. (ATYR) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Michael K. Wirth.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
ATYR currently screens at market cap $471.7M. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the ATYR and CVX stock pages for the full models.
Not investment advice.